Study shows how fat fuels cells in brain tumors
A new study led by Loic Deleyrolle, Ph.D., an assistant professor of neurosurgery, has implications for advancing new metabolic therapies for glioblastoma, the deadliest form of brain cancer.
Posted in
Uncategorized
Article examines nusinersen benefits in forms of spinal muscular atrophy
A new article examining data from clinical trials led by Melissa Armstrong, M.D., an assistant professor of neurology, shows that nusinersen treatment benefits certain patients with spinal muscular atrophy.
Stem cells could clear path for immunotherapy in brain cancer
A new discovery led by Dr. Catherine Flores using stem cells to overcome resistance to immunotherapy drugs may open the door to more effective treatment for brain cancer.
Research Snapshots: Jolie Barter & Dr. Thomas Foster
The role of epigenetics in the process of brain aging and cognitive decline.
Dementia with Lewy bodies study examines end-of-life experiences
Melissa Armstrong, M.D., an assistant professor of neurology, partnered with the Lewy Body Dementia Association to survey the families of patients who had dementia with Lewy bodies.
Challenges in defining inappropriate medication use in Parkinson’s dementia
In a recent editorial in JAMA Neurology, a group of neurologists at at The Fixel Center for Neurological Diseases at UF Health discuss medication trends for Parkinson's disease dementia.
eNeuro highlights study by UF Center for Addiction Research & Education researchers
Addiction research led by Drs. Caitlin Orsini and Marcelo Febo, was recently chosen as a Research Highlight in the journal eNeuro.
2018 Nobel Prize in Medicine: A turning point in the war on cancer
In The Conversation, Dr. Duane Mitchell discusses the importance of Drs. James Allison and Tasuku Honjo's discoveries in immunotherapy.
Ted Turner has Lewy body dementia, but what is that?
In The Conversation, Dr. Melissa Armstrong explains LBD, how it's diagnosed and current avenues for researching the disease.
